Clinical trial
Pharmacogenetics of Risperidone in Children With Pervasive Developmental…
NCT00166595 · Children's Hospital Medical Center, Cincinnati, Other · Completed
Key facts
| NCT number | NCT00166595 |
|---|---|
| Title | Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD) |
| Official title | Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD) |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Child Development Disorders, Pervasive |
| Intervention type | Drug |
| Interventions | Risperidone |
| Enrollment | 100 |
| Start date | Feb 1, 2003 |
| Completion | Mar 1, 2005 |
| First posted | Sep 14, 2005 |
| Last update posted | Jan 28, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: